That is correct.
Access to COVID-19 convalescent plasma is either by participating in clinical trials or for severe to life threatening cases via single patient emergency investigational new drug application (where FDA approval is required to administer it with strict criteria to access the plasma).
- Forums
- ASX - By Stock
- Coronavirus
That is correct.Access to COVID-19 convalescent plasma is either...
-
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$307.90 |
Change
-0.020(0.01%) |
Mkt cap ! $148.7B |
Open | High | Low | Value | Volume |
$307.40 | $307.90 | $304.87 | $201.6M | 655.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 863 | $307.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$307.92 | 211 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 863 | 307.510 |
1 | 1219 | 307.060 |
1 | 71 | 307.000 |
1 | 1219 | 306.850 |
1 | 1219 | 306.630 |
Price($) | Vol. | No. |
---|---|---|
307.920 | 211 | 1 |
307.940 | 200 | 1 |
307.970 | 1000 | 1 |
307.990 | 1000 | 1 |
308.000 | 1879 | 9 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online